CD5-positiverituximab背景:濔漫性大B細胞淋巴瘤(diffuse large B-cell lymphoma, DLBCL)是最常見的非何杰金氏淋巴瘤,且也是一個由多種疾病所組成的一群疾病。案例描述:在此,我們報告一位罹患「原發性CD5陽性濔漫性大B細胞淋巴瘤」(de novo CD5-positive DLBCL)的病人,以右側骼骨附近、右側鼠蹊部附...
Mantle cell lymphoma (MCL) is a low grade B-cell lymphoma; patients with this lymphoma have widespread nodal disease at the time of diagnosis, although local extranodal disease has also been reported in some cases. It is uncertain whether these two disease are identical. To determine the relati...
TRANSLOCATION (11;14)(q13;q32) IN CD5‐POSITIVE B‐CELL LYMPHOMA ASSOCIATED WITH HAEMOPHAGOCYTIC SYNDROMEhaemophagocytic syndromeB-cell lymphomat(1114)(q13q32bcl-1mantle cell lymphomaComment on Br J Haematol. 1999 Mar;104(4):672-9.
【关键词】 弥漫大 B 细胞淋巴瘤; CD 5 ; 临床特点;分子预后因素;生存 【中图分类号】 丨 U 33.4; R 55 【文献标志码】 ADOI : 10. 13820/ j . cnki . gdyx . 20191865Clinical and prognostic features of primary diffuse large B - cell lymphoma with CD5 expression. WANG Bao - feng, HU ...
【关键词】CD5_/J、B细胞淋巴瘤毛细胞白血病淋巴浆细胞淋巴瘤滤泡性淋巴 瘤边缘区淋巴瘤 。。 3 ClinicalFeaturesof SmaUB—ceIl CD5一negatiVe Lymphoma Abstract objective iIl Tb theclinicalf.eaturesofdiseaSesincludedCD5’sm猷lB—cell inVestigate andmech娥lcteristicsof zone lymphom“SBCL) pres眦lptiVespl...
is an adverse prognostic factor in diffuse large B-cell lymphoma,Ann Arbor stage,immunohistochemistry classification and treatment with rituximab are independent prognostic factors for overall survival of CD5-positive dif-fuse large B-cell lymphoma.%目的:探讨 CD5阳性弥漫大 B 细胞淋巴瘤的预后...
【摘要】目的 探讨CD5阳性的弥漫性大B细胞淋巴瘤(diffuse large B cell lymphoma,DLBCL)的临床病理特征及临床预后意义.方法 分析13例CD5阳性的DLBCL的临床资料、组织学特点、免疫表型及临床随访资料,并复习相关文献.结果 13例DLBCL组织CD5抗原阳性,阳性反应定位于肿瘤细胞膜,全部表达B系列抗原CD20、CD79a.组织学特征...
CD5(套层细胞淋巴瘤标记)抗体,克隆 4C7,CD5 (Mantel Cell Lymphoma Marker); 4C7 其他 ScyTek公司始建于1991年,以成为世界级生命科学研究试剂生产商为目标。ScyTek从创立之初就采取了严格的原材料筛选程序,生产多种优质试剂,不断应用于各种学科,包括免疫学,组织学,细胞学,微生物学和血液学等。ScyTek公司的ELISA...
摘要 Objective To explore the biological characteristics of primary CD5 positive diffuse large B-cell lymphoma (DLBCL) and treatment effects of rituximab combined with different chemotherapy regimens. Methods The clinical features of 2 CD5 positive DLBCL patients (1 case with early report and 1 ...
The recent World Health Organization (WHO) classification defines mantle cell lymphoma (MCL) as a distinct entity characterized by a unique immunophenotype and a molecular hallmark of chromosomal translocation t(11;14)(q13;q32). We report an unusual case of an advanced stage of CD5 negative MCL...